Navigation Links
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
Date:4/29/2009

ths of treatment. At the end of the initial 6 months, all patients will be dosed on a PRN (as needed) basis for another 6 months. All patients will be eligible for rescue laser treatment.

About VEGF Trap-Eye

Vascular Endothelial Growth Factor (VEGF) is a naturally occurring protein in the body whose normal role is to trigger formation of new blood vessels (angiogenesis) to support the growth of the body's tissues and organs. It has also been associated with the abnormal growth and fragility of new blood vessels in the eye and vascular permeability and edema. VEGF Trap-Eye is a fully human, soluble VEGF receptor fusion protein that binds all forms of VEGF-A along with the related Placental Growth Factor (PlGF). Investigational VEGF Trap-Eye is a specific blocker of VEGF-A and PlGF that has been demonstrated in preclinical models to bind these growth factors with greater affinity than their natural receptors.

Regeneron and Bayer HealthCare are collaborating on the global development of VEGF Trap-Eye for the treatment of wet AMD, DME, CRVO, and other eye diseases and disorders. Bayer HealthCare will market VEGF Trap-Eye outside the United States, where the companies will share equally in profits from any future sales of VEGF Trap-Eye. Regeneron maintains exclusive rights to VEGF Trap-Eye in the United States.

About Regeneron Pharmaceuticals

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST(R) (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, inflammatory diseases, and pain and has preclinical programs in other diseases and disorders. Additional information about Regeneron and recent news releases are
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.; Bayer HealthCare AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
2. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
3. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
4. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
5. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
6. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
7. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
8. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
9. New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting
10. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
11. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... First Choice Wellness Care recently upgraded their ... is the only clinic in the greater ... The practice has recently expanded their services and added ... their focus in the procedure. They upgraded to the ... clearance, and superior service. "We,ve been providing ...
(Date:6/30/2015)... , June 30, 2015 Today, UBM China, ... an agreement with Chengdu Tianyi Exhibition Co., Ltd. to ... which is to be held concurrently with CWMEE 2016. ... UBM,s healthcare exhibition family, following MEDTEC China and DENTECH ... market in west China. It,s also another concrete cooperative ...
(Date:6/30/2015)... , June 30, 2015 Oramed ... a clinical-stage pharmaceutical Company focused on the development of ... patient has been screened in the Company,s Phase IIb ... based study will be performed under the active Investigational ... Food and Drug Administration (FDA). The Phase ...
Breaking Medicine Technology:First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3UBM Joins Chengdu Tianyi to Hold CWMEE 2016 2UBM Joins Chengdu Tianyi to Hold CWMEE 2016 3Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 3
... WOODLANDS, Texas, Oct. 27, 2011 Lexicon Pharmaceuticals, ... company focused on discovering breakthrough treatments for human disease, ... 2011 financial results on Tuesday, November 1, 2011 before ... conference call to discuss program status and financial results ...
... Oct. 27, 2011 Cardica, Inc. (Nasdaq: CRDC ... ended September 30, 2011. Cardica,s management will host a conference ... financial results and provide an update on the company,s business. ... team of Dr. Swanstrom, a world-renowned key opinion leader in ...
Cached Medicine Technology:Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2011 Financial Results 2Cardica Announces Fiscal 2012 First Quarter Financial Results 2Cardica Announces Fiscal 2012 First Quarter Financial Results 3Cardica Announces Fiscal 2012 First Quarter Financial Results 4Cardica Announces Fiscal 2012 First Quarter Financial Results 5Cardica Announces Fiscal 2012 First Quarter Financial Results 6
(Date:6/30/2015)... ... June 30, 2015 , ... ... Post-Acute Rehab”. The video focuses on the rehab center’s patients and their experiences ... provides the best quality of services available. Each patient attests to the high ...
(Date:6/30/2015)... ... , ... Broadway by the Sea posted its newest YouTube video today, “Broadway ... rated the care center as a five-star location based on a comprehensive evaluation of ... a firsthand look at the facility’s satisfied residents. , “In this new video, ...
(Date:6/30/2015)... New York (PRWEB) , ... June 30, 2015 ... ... ( http://www.xareltolawsuit2015.com/ ) currently pending in a federal multidistrict litigation now underway in ... Court convenes its next monthly Status Conference. According to the Court’s calendar, that ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... , Eleven physicians from Allied’s Fullerton division volunteered to help provide free outpatient ... Surgery Saturday, March 21, at St. Jude Medical Center. , The event ...
(Date:6/30/2015)... ... June 30, 2015 , ... Red Hot & Blue ... recent online poll at http://scoutology.com/novaburgerwars and was selected as “Best BBQ” in ... August 2015. , Red Hot & Blue President Randy McCann said, “Everyone knows Red ...
Breaking Medicine News(10 mins):Health News:Patients of University Post-Acute Rehab Support Five-Star Rating in New Video 2Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 3Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 2Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 3
... health threat, especially in underdeveloped areas , , TUESDAY, ... but neglected threat to global public health, new research ... PLoS Medicine , estimates that at least 421,000 ... suggesting the numbers could be as much as four ...
... NEW BRUNSWICK, N.J., Nov. 4 Senesco,Technologies, Inc. ... announced that the Company will be presenting at ... is being held at the New York,Palace Hotel ... President,Corporate Development of Senesco, will deliver the Company,s ...
... Diluted EPS(1) of $0.37 -, - Expects Fourth Quarter ... Expects 2009 Sales Growth of 7% to 9%, Excluding Currency ... -, LIONVILLE, Pa., Nov. 4 West Pharmaceutical,Services, Inc. ... quarter of,2008. Reported diluted earnings per share of $0.40 included ...
... 4 Cell Biosciences, Inc., a,provider of protein ... announced the launch of its first assay kits ... 3000 is an,ultrasensitive nano-immunoassay system that quantifies the ... 25 cells., The new Firefly 3000 Focusing ...
... AlBaraka Islamic Bank has,announced that it has selected Misys ... branches in Pakistan. The new contract,builds on a number ... Misys across Africa and the Middle East., Shafqaat ... of our growth strategy involving conversion of our Pakistan ...
... the Connecticut Breastfeeding Coalition,s Breastfeeding-Friendly Business Award. , ... ... LifeCare®, Inc. , longtime leader in the work/life industry, ... is one of only five Connecticut organizations to receive the ...
Cached Medicine News:Health News:Senesco Technologies to Present at 10th Annual Rodman & Renshaw Healthcare Conference 2Health News:Senesco Technologies to Present at 10th Annual Rodman & Renshaw Healthcare Conference 3Health News:West Announces Third Quarter 2008 Results 2Health News:West Announces Third Quarter 2008 Results 3Health News:West Announces Third Quarter 2008 Results 4Health News:West Announces Third Quarter 2008 Results 5Health News:West Announces Third Quarter 2008 Results 6Health News:West Announces Third Quarter 2008 Results 7Health News:West Announces Third Quarter 2008 Results 8Health News:West Announces Third Quarter 2008 Results 9Health News:West Announces Third Quarter 2008 Results 10Health News:West Announces Third Quarter 2008 Results 11Health News:West Announces Third Quarter 2008 Results 12Health News:West Announces Third Quarter 2008 Results 13Health News:West Announces Third Quarter 2008 Results 14Health News:West Announces Third Quarter 2008 Results 15Health News:West Announces Third Quarter 2008 Results 16Health News:West Announces Third Quarter 2008 Results 17Health News:West Announces Third Quarter 2008 Results 18Health News:West Announces Third Quarter 2008 Results 19Health News:West Announces Third Quarter 2008 Results 20Health News:AlBaraka Islamic Bank Builds on a Long-Term Partnership With Misys Selecting Misys Equation and Trade Innovation for its Pakistan Operations 2Health News:AlBaraka Islamic Bank Builds on a Long-Term Partnership With Misys Selecting Misys Equation and Trade Innovation for its Pakistan Operations 3Health News:LifeCare Wins Breastfeeding-Friendly Business Award from Connecticut Breastfeeding Coalition 2
... The Medtronic Subcutaneous Lead System ... subcutaneously with the use of ... 6996T. Improved SQ design and ... a fast and easy procedure, ...
The Livewire steerable electrophysiology catheter is uniquely designed with an ergonomic handle and patented steering mechanism to provide smooth, precise catheter tip movement, even during lengthy e...
... The Medtronic Sprint™ ... and the CapSureFix® Novus ... deliver superior electrical performance ... excellent sensing capabilities, low ...
... The SOLX DeepLight Glaucoma Treatment ... yet highly effective glaucoma treatments ... DeepLight Gold Micro-Shunt (GMS) and ... that help use the eye's ...
Medicine Products: